O ptimal sedation management is an integral component of the comprehensive medical care of a mechanically ventilated child. The heterogeneity in ages and diagnoses in the PICU can create particular challenges in sedation of intubated children, with a myriad of physiologic considerations for each sedative or analgesic medication administered in a given clinical situation. Adequate sedation and analgesia are required for the comfort and safety of the child as well as to promote patient-ventilator synchrony. The frequent noise and bright lights of the PICU environment and the recurrent interventions by the medical care team add to the stressors that a child experiences when critically ill, and unlike adults, many children cannot cooperate with or understand the need for medical instrumentation and interventions (1) . These factors combined with the development of physiologic tolerance often lead to a cycle of increasing sedative and analgesic medications to maintain a child's comfort and safety and improve sleep.
Most medications used for sedation and analgesia in the PICU, commonly opioids and benzodiazepines, are known to decrease slow-wave sleep and rapid-eye movement (REM) sleep (2, 3) . In addition, benzodiazepines are a strong independent risk factor for the development of delirium (4, 5) . ICU delirium increases morbidity and mortality in critically ill adults, and emerging evidence suggests that delirium may be clinically relevant in critically ill children (6) (7) (8) (9) . Normal sleep-wake homeostasis has a critical role in immunity and thermoregulation, as well as prevention of delirium and the development of a catabolic state, which may influence the rate of recovery from critical illness (2, 10) .
There is no universally accepted goal-directed approach to sedation of mechanically ventilated children. The sedative and analgesic medications available for use in the PICU can vary from hospital to hospital, and choice of specific medications may differ in different areas of the world. As care providers change over the course of a child's PICU admission, variations in sedation goals and approaches may be introduced from both physicians and nurses. In addition to the pharmacologic management of sedation and analgesia, many nonpharmacologic adjunctive approaches have been described in adult and pediatric critical care literature, including sleep promotion and early delirium recognition (1, 2, 8, 11, 12) . To characterize the current state of practice internationally, we designed a detailed survey to describe the experiences and approaches of pediatric intensivists with regard to sedative availability, preferences and strategies, PICU environment, sleep optimization, and delirium recognition and treatment. We hypothesized that there is significant variability in the approaches to sedation of the child requiring long-term mechanical ventilation and predict that sleep promotion and delirium screening are not routinely practiced in PICUs internationally.
METHODS
On July 5, 2012, the World Federation of Pediatric Intensive and Critical Care Societies (WFPICCS) invited all member societies to send the electronic survey to their membership. The survey was administered by Survey Monkey (http://www.surveymonkey.com) and was also made available by a direct link from the WFPICCS Internet homepage. In September 2012, a reminder was sent in the WFPICCS newsletter. All participants were informed that individual responses would remain anonymous and confidential. The survey closed to further responses on January 15, 2013. Survey questions and topics were developed by content experts in the fields of pediatric critical care medicine and pediatric anesthesiology, and the survey was pilot tested among multiple pediatric intensivists for feedback regarding question clarity and the survey interface. WFPICCS leadership and the Johns Hopkins Institutional Review Board approved the study and final survey for distribution.
The survey was in English and consisted of 40 questions divided into four sections by concept. The first section ascertained particular demographics, including the size and type of hospital, number of years the intensivist had been in practice, and if the institution had a fellowship training program. Respondents were also asked about the physical layout of their PICU. The second section asked about medications available in the PICU, whether any sedative or analgesic agents had restrictions, and their preferences in medication for children who they anticipated to require mechanical ventilation longer than 24 hours. The third section had questions regarding sedation protocols/algorithms used in their PICU and methods used for sedation assessment. The last section gathered information about PICU sleep promotion and delirium screening practices. Questions were closed-ended, multiple-choice design, but many included an "other" option for a free-text response. The questionnaire is included as an online supplement (Supplemental Digital Content 1, http://links.lww. com/CCM/A963) to this article.
Data were analyzed with the statistical software package STATA version 11.0 (StataCorp LP, College Station, TX). Characteristics of respondents were summarized with frequencies and proportions for categorical variables and means and SDs for continuous variables. Medication preferences and availability were compared across intensivist demographics and other survey responses by using chi-square analysis.
RESULTS

Intensivist and PICU Demographics
Demographic data for intensivist respondents and the PICU settings are shown in Table 1 . In total, 341 respondents participated in the electronic survey through the e-mail link or online invitation. The majority of attending physician respondents (81%) had more than 5 years of experience caring for critically ill children, and most respondents (56%) reported their primary practice setting as an academic university. Across the sample, the PICUs were reported to accommodate an average of 17.6 (SD, 12.1) critically ill children. As shown in Figure 1 , North America was the continent with the largest proportion of respondents (70%), followed by Europe (14%) and Asia (9%).
Sedation Monitoring of Mechanically Ventilated Children
Written sedation protocols with treatment algorithms were in place in only 27% of the respondents' PICUs, and of those, 52% of the sample reported that the protocols were physician-driven ( Table 2) . North American respondents reported a higher percentage of nursing-driven protocols (58%; p = 0.02). A physician-driven protocol was defined as one from which the physician directs all medication and dosing changes, in contrast to a nursing-driven protocol where the nurse has the ability to independently titrate medications to the desired level of sedation, within set limits as defined by an initial physician order. Sedation scoring systems, defined as a tool used to assess depth of sedation and set patient-specific goals for sedation, were in place in 70% of the respondents' PICUs, but only 42% stated that they were used as a routine part of daily rounds and patient-care goals. Eleven percent reported that although a sedation scoring system existed in their PICU, it was never used. Most commonly used sedation scoring scales included COMFORT (37%), State Behavioral Scale (SBS; 24%), and Ramsay (18%). Although 72% reported that the bispectral index monitor (BIS) was not available in their unit, 4% reported consistent use of this modality for mechanically ventilated children.
Sedative-Analgesic Medication Preference
In response to a question regarding preferred initial sedative regimen for a child with primary respiratory failure, 72% of survey participants chose a combination of opioid and benzodiazepine, whereas 12% preferred an opioid alone, 8% preferred using an opioid with dexmedetomidine, and only 1% used a combination of benzodiazepine and dexmedetomidine. Less than 1% used dexmedetomidine alone when initiating a sedation regimen. Interestingly, 2% reported the routine use of propofol in the initial sedation regimen, and this was always in combination with an opioid and benzodiazepine. Similarly, 2% used ketamine routinely along with an opioid and benzodiazepine.
Most respondents (66%) preferred fentanyl as the opioid for analgesia during sedation, whereas 28% preferred morphine, although respondents from countries outside of North America demonstrated a more even preference in comparison-42% for fentanyl and 46% for morphine ( Fig. 2) (p < 0.001). The majority (93%) chooses to administer opioid as a maintenance infusion when it is used as part of a sedation regimen. Midazolam was the benzodiazepine of choice for most respondents (86%) (Fig. 3) followed by lorazepam (12%). Similar to opioid administration, most intensivists initiate benzodiazepines as a maintenance infusion (80%), with equal proportions choosing scheduled interval dosing and as-needed dosing (10% each). Propofol and dexmedetomidine were the most commonly restricted drugs for sedation in PICUs. Of 246 respondents who have dexmedetomidine available at their institution, 25% stated that they have either duration or indication restrictions.
PICU Layout, Sleep Promotion, and Delirium Screening
As shown in Figure 4 , the majority of North American respondents (62%) reported that their PICU consists of all private rooms, in contrast to 11% for all other countries (p < 0.001). Seventy-seven percent of all respondents reported that all patient rooms had windows, and 4% reported no windows in any of the patient rooms. A small proportion reported the presence of unit protocols to optimize noise (16%) and light exposure (9%) for sleep promotion. Of those surveyed, 78% had never observed earplug use in their PICU, and 65% had never observed use of eye masks. Of those who had observed eye mask or earplug use, 5% and less than 1%, respectively, reported consistent use for all mechanically ventilated children. Seventy-one percent of respondents reported that their unit does not perform routine delirium screening, and only 2% reported that delirium screening is performed on every 
Free-Text Responses
Fifty-four respondents provided detailed comments regarding sedation of mechanically ventilated children. One common theme was frustration over inconsistencies in sedation goals. Many intensivists voiced concerns that bedside nurses often want a child to be immobile, without any signs of awareness, leading to oversedation. Several expressed interest in pursuing delirium education due to concerns that agitated, critically ill children may be receiving additional doses of psychoactive medications instead of therapy for what may actually be undiagnosed delirium.
DISCUSSION
Our study is the first international survey to characterize sedation, sleep promotion, and delirium screening practices in the pediatric population. We found that despite the need for, and near universal application of, pharmacologic sedation in the PICU, a minority of programs have formalized methods of sedation assessment, drug choice and delivery, or therapeutic goal direction. Unlike the adult and neonatal ICUs, sleep promotion is exceedingly uncommon in the PICU. Finally, the interplay between sedation, sleep, and ICU delirium is not prioritized in PICU management, even though delirium prevention with nonpharmacologic behavioral interventions including sleep promotion has become a major therapeutic initiative in the care of critically ill adults. Thus, we found significant variation in practice, with many opportunities for future study and therapeutic intervention in a population undergoing active neurocognitive development. Our finding that less than one third of respondents use a standardized, unit-wide, written sedation protocol for mechanically ventilated children is different from that of a previous survey of PICU fellowship programs in which 66% reported the use of a written sedation policy (13) . This difference is likely due to the survey questions themselves, as we defined the written sedation protocol to be a specific algorithm that is consistently used in the PICU, in contrast to a written sedation policy, which may be more general and used as a guideline. The current study was an international survey that encompassed teaching and nonteaching hospitals, whereas the previous study was limited to only American fellowship program directors with a 59% response rate. Nevertheless, we found that even in PICUs with fellowship programs, the minority (35%) used standardized sedation protocols, and subgroup analysis demonstrated no significant difference in the use of sedation protocols (p = 0.73) and sedation scoring (p = 0.13) between private and university-based respondents.
A growing body of literature has demonstrated the benefit of standardized sedation treatment algorithms in critically ill adults. Sedation protocols in the adult ICU have been shown to decrease days of mechanical ventilation, reduce hospital length of stay, and promote earlier ambulation. Perhaps most importantly, it reduces the prevalence and severity of delirium, a negative consequence of critical care (14) (15) (16) . A small number of published studies suggest that these benefits extend to pediatrics, and a large multicenter randomized controlled trial is ongoing (17) (18) (19) .
Much to our surprise, we found that most intensivists do not use formalized methods of sedation assessment to guide drug choice and delivery, although several validated measures exist. The COMFORT score continues to be the most commonly used scoring system overall, although North American respondents report increased usage of the SBS and Richmond Agitation-Sedation Scale (RASS) compared to that in a previous U.S. survey (13) . The SBS was designed and validated in 2006 to define the sedation-agitation continuum in critically ill infants and children to guide goal-directed therapy (20) . RASS, the sedation scale most commonly used in critically ill adults, has not been validated in critically ill children (21). Even when respondents stated that there was a specific sedation scoring system designated in their PICU, the majority do not consistently use them to set goals for sedation management on a day-to-day basis. This finding is concerning because sedation is not one-size-fits-all. Rather, it requires titration to effect. Thus, the failure to measure the level of sedation and to actually use these measures to guide and titrate therapy may result in oversedation or undersedation, both of which have the potential to produce significant patient morbidity and mortality. Within a complex team framework of nurses, residents, nurse practitioners, fellows, respiratory therapists, and attendings who provide and manage sedation, the use of a streamlined sedation scoring tool in conjunction with a goal-directed treatment algorithm is imperative to facilitate consistent communication and optimal therapy.
A small proportion of care providers use automated tools such as the BIS for bedside monitoring of sedation. Initially designed to decrease the prevalence of intraoperative awareness during general anesthesia in adults, the BIS monitor uses an algorithmic analysis of the electroencephalogram (EEG) to provide a single, dimensionless number to guide titration of anesthetic agents (22) . Because the algorithm of the BIS monitor is derived from adult EEG data and the EEG of children changes as the brain matures, it remains controversial whether BIS can be generalized to infants and children in the operating room and ICU settings (23) (24) (25) (26) .
We found substantial differences in how sedation is provided, particularly in regard to drug preferences and delivery. Although most providers choose a combination of opioid and benzodiazepine as their initial regimen for sedation and analgesia, many opt for opioid alone. Opioids are primarily analgesics that produce sedation and either euphoria or dysphoria as wanted or unwanted side effects. Opioid alone may be chosen by PICU providers because they are less likely to adversely affect hemodynamics and are perceived as short-acting, an erroneous notion given the increased context-sensitive half-life when administered as a continuous infusion (27, 28) . This is especially true for fentanyl, now the most commonly prescribed opioid in North American PICUs, supplanting morphine (13) . Opioid use as a primary sedative agent in the PICU warrants concern due to a lack of anxiolytic and amnestic properties at low doses, leading to dose escalation to achieve the desired level of sedation and increased risk of tolerance and withdrawal. In addition, the child receiving opioid as a primary sedative is exposed to an increased risk of all the adverse effects associated with both long-term and high-dose opioid use, including gastrointestinal dysmotility that may lead to feeding intolerance during a period when optimal nutrition is crucial.
Fentanyl may also be chosen in the PICU due to its hepatic clearance, facilitating use in children who have renal insufficiency. Although data are limited, the choice of fentanyl over morphine in the PICU may also be influenced by morphine's association with histamine release, which may concern care providers when potential hypotension is an undesirable risk (29, 30) . Morphine is the most inexpensive opioid available. Emerging evidence has shown that when used as an infusion it is more favorable than fentanyl with regard to need for dose escalation, prevalence of withdrawal, and length of hospital stay (31, 32) . Opioid tolerance and withdrawal pose major challenges for all providers in the PICU, and the predilection for fentanyl may be a trend that needs further evaluation through a randomized controlled trial.
Midazolam is the benzodiazepine most commonly used for sedation in mechanically ventilated children. Benzodiazepines are gamma-aminobutyric acid type A agonists that are sedative/hypnotic/amnestics with little to no analgesic property. Midazolam has a short plasma half-life, has rapid onset, and is amenable to titration as a continuous infusion. Although benzodiazepines provide the benefits of amnesia, anxiolysis, and sedation, one major disadvantage is the increased risk of delirium with prolonged administration (4, 5, 12, 33) . Adult guidelines for long-term sedation recommend lorazepam, based on high-grade evidence that lorazepam infusions require fewer dosage adjustments, require less time to achieve adequate sedation, and provide more predictability for awakening times and time to extubation compared to midazolam (14, 34, 35) . Midazolam pharmacokinetics and pharmacodynamics have been shown to change with age, leading to significant interindividual variability (26, 36, 37) . To date, direct comparisons of midazolam and lorazepam have not been made in the PICU population, and data are limited on the use of diazepam in the ICU setting (38) . Consistent with other ICU surveys, we found that diazepam is rarely used as a first-line sedative agent in mechanically ventilated children (13, 38, 39) .
Dexmedetomidine, an α-2 adrenergic agonist with analgesic, sedative, and anxiolytic properties, has emerged over the last decade as an attractive option for sedation of critically ill children because of its favorable hemodynamic profile and preservation of respiratory function (40) . Compared to all sedatives and analgesics available, dexmedetomidine has been shown to induce an EEG pattern with the most similarities to natural sleep (41) (42) (43) . Most respondents did not report restrictions on the use of dexmedetomidine in their units, yet only 10% include it as part of the initial regimen. Although the currently patent-protected dexmedetomidine is more expensive than the commonly used benzodiazepines, studies have demonstrated comparatively less cost because time to extubation and ICU and hospital length of stay are reduced (44) . Dexmedetomidine has been associated with decreased opioid and benzodiazepine administration in critically ill children as well as decreased inotropic support (45) (46) (47) . Despite these favorable qualities, anecdotal evidence suggests that long-term use of dexmedetomidine infusions can result in physiologic tolerance, withdrawal, and adrenal insufficiency (48) (49) (50) (51) . Therefore, additional study is warranted.
Our survey demonstrates a clear preference for continuous infusions over scheduled, intermittent dosing of sedatives and analgesics during mechanical ventilation. Continuous infusions are advantageous because they are titratable, maintain steadystate plasma drug levels, decrease catheter breaks and infection risk, and are less labor-intensive for a busy critical care nurse. Disadvantages include potential for oversedation from drug accumulation and, perhaps more important, an increased risk for tolerance and escalation of sedative and analgesic doses (52) (53) (54) . Intermittent, scheduled dosing of sedative and analgesic medications in the appropriate target population may effectively provide many of the purported benefits of sedation interruption, while exposing a child to decreased overall doses of psychoactive medications (55, 56) . These benefits must be considered alongside with the potential increase in nursing workload necessary to care for an awake, critically ill child (57) .
Finally, this study underlines an impending and critical need for sleep promotion and delirium screening in critically ill pediatric patients. Sedatives and analgesics are often increased to improve the subjective assessment of "sleep," yet these very medications decrease restorative sleep, leading to a vicious cycle of sleep disturbances that manifest as agitation and delirium (2) . A small number of studies that have objectively evaluated sleep in critically ill children have shown significant decreases in slow-wave sleep and REM sleep, which are integral to neuronal development in childhood (1) . Despite the availability of proven, noninvasive, and inexpensive modalities such as earplugs and eye masks to decrease sleep interruptions during nighttime hours, such methods are rarely used in adult and PICU settings (11, 58, 59) .
A minority of PICUs employ noise-reduction strategies to target World Health Organization-recommended levels of noise (< 30 dBA Leq day and nighttime). Several studies have demonstrated that ICU noise levels are frequently greater than 50 dBA throughout a 24-hour period, with several intermittent peaks to more than 80 dBA (60, 61) . Private rooms provide some protection from general ICU noise and may improve the quality of patient sleep (62) . Light levels are also integral to maintaining circadian rhythmicity during critical illness. Receiving exposure to natural light during the daytime and minimizing nighttime light exposure are necessary for hormonal regulation, specifically melatonin secretion, to optimize the sleep-wake cycle (63, 64) .
Delirium in critically ill children is emerging as an extremely important diagnosis that must be recognized by all pediatric intensivists (8, 9, (65) (66) (67) . A combination of critical illness, sedative-analgesic medications, and sleep disruption place the mechanically ventilated child at increased risk for delirium. Consequences can include increased morbidity and mortality from prolonged intubation and weaning of medications. Despite the availability of validated tools for delirium screening and diagnosis, our study draws attention to a PICU culture that does not prioritize this important diagnostic consideration. The low prevalence of PICU delirium screening may be related to multiple factors, including knowledge gaps surrounding the importance of delirium in critically ill children, availability of resources to perform unit-wide screening, and accessibility of therapies for treatment of delirium. Several respondents listed withdrawal screening tools such as the SOS and WAT-1 as their method of delirium screening, highlighting the need for widespread delirium education. Underrecognition of delirium may also be secondary to the reluctance of intensivists to engage the pediatric neuropsychiatrist as yet another consultation team, whose recommendations for nonpharmacologic and pharmacologic therapies may seem challenging for an already burdened patient, family, and PICU team.
Most survey results were similar across respondents internationally, although there were some interesting differences. The preference for fentanyl as the first-line opioid is higher in North America compared to all other countries, which may be due to differences in cost considerations or simply PICU culture that has been propagated based on fentanyl's purported advantages over morphine. North American respondents also reported a higher percentage of nursing-driven sedation protocols, which may reflect an increasing focus on nursing autonomy in patient care as a predictor of greater job satisfaction and improved patient care within a team framework (68) (69) (70) .
The current study has some notable limitations. First, the respondents may not be representative of PICU practitioners internationally, as the 341 respondents are a small proportion of all intensivists caring for critically ill children. It is also possible that, as a result of "chain sampling," several respondents work in the same PICU, which may lead to bias; other PICUs may not have been represented if no staff member received the survey link. Second, a respondent's practice may differ significantly from others in their center, potentially decreasing generalizability. Additionally, there was a higher proportion of responses from North American intensivists, which may decrease the generalizability of data on the international level. Finally, another limitation stems from questions the survey did not ask. For example, issues such as sedation interruption, rotation, weaning practices, or use of neuromuscular blockade were not included in the survey. Nevertheless, our study delineates the international heterogeneity of practice and differing approaches to sedation, sleep, and delirium in critically ill children.
CONCLUSIONS
Despite the need for, and near universal application of, pharmacologic sedation in the PICU, only a minority of intensivists use formalized methods of sedation assessment, drug choice and delivery, or even therapeutic goal direction. This study highlights the heterogeneity in sedation practices among pediatric intensivists as well as a paucity of sleep promotion and delirium screening in PICUs worldwide. Thus, numerous opportunities exist for future study and therapeutic intervention in a population undergoing active neurocognitive development.
